DXCM vs TPCS · P/E 63, rev $4.03B vs rev $34.0M
DexCom Inc (DXCM) versus TechPrecision Corporation Common stock (TPCS) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
TechPrecision Corporation Common stock (TPCS) is a metal fabrication company listed on NASDAQ.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported TPCS revenue for 2025-03-31 was $34.0M. Net income was -$2.7M. Revenue was up 7.7% from 2024-03-31 to 2025-03-31. TPCS currently screens at market cap $34.5M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. TPCS currently screens at market cap $34.5M.
Not investment advice. Open the DXCM and TPCS stock pages for the full models.
Not investment advice.